Tag: NASDAQ

Posted on

Article: Stocks Dump’n’Pump; Dollar Gains Amid Bitcoin, Bond Pain

Article - Media, Publications

Stocks Dump’n’Pump; Dollar Gains Amid Bitcoin, Bond Pain

Tyler Durden,25 March 2021

Thanks to yet another big short-squeeze that began shortly ahead of the EU close. This was the biggest short-squeeze since late January. Small Caps went from down over 1.5% ahead of the EU close to up over 2.5%. Nasdaq ended lower as late day selling pressure hit…

Before today, the last six days have seen the market has dropped in the last hour. S&P and Dow are back to unch on the week, Nasdaq remains red and Small Caps still down over 4.3%.Value outperformed Growth today but both ripped off the EU close…

Read Full Article

Posted on

Article: Farmmi Closes $7.4 Million Underwritten Public Offering of Ordinary Shares

Article - Media, Publications

Farmmi Closes $7.4 Million Underwritten Public Offering of Ordinary Shares

PRNewswire, 24 March 2021

Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI), an agriculture products supplier in China, today announced the closing of an underwritten public offering of 6,469,467 ordinary shares of the Company, at a price to the public of $1.15 per share. In addition, the Company has granted the underwriter an option to purchase an additional 15 percent of the ordinary shares offered in the public offering solely to cover over-allotments, if any, exercisable for 25 days, after the closing of this offering, which would bring total gross proceeds to approximately $8.6 million. The Company intends to use the net proceeds from this offering for general corporate and working capital needs.

Read Full Article

Posted on

Article: 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

Article - Media, Publications

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

GLOBE NEWSWIRE, 24 March 2021

180 Life Sciences Corp. (NASDAQ: ATNF, the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3 clinical trial, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today released the following letter to stockholders from its Chief Executive Officer, Dr. James Woody. Continue reading “Article: 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders”

Posted on

Article: SEC Confirms Probe of SoftBank

Article - Media, Publications

SEC Confirms Probe of SoftBank

Michelle Celarier, 24 March 2021

SoftBank is the subject of an active investigation by the Securities and Exchange Commission, according to PlainSite, a legal transparency initiative.

The research provider on Wednesday shared the SEC’s response to a Freedom of Information Act request by Aaron Greenspan, the founder of PlainSite, a joint venture of Think Computer Corporation and Think Computer Foundation.

Greenspan said the SEC probe appears to be related to SoftBank’s trading unit, SB Northstar. He told Institutional Investor that news last year about SoftBank’s options trading triggered his initial FOIA request, which was dated December 2, 2020. Continue reading “Article: SEC Confirms Probe of SoftBank”

Posted on

Article: Form 424B5 Farmmi, Inc.

Uncategorized

Form 424B5 Farmmi, Inc.

Toppan Merrill/FA, 23 March 2021

We are offering 6,469,467 ordinary shares, at a public offering price of $1.15 per ordinary share, pursuant to this prospectus supplement and the accompanying prospectus. See “Description of Ordinary Shares” in the accompanying prospectus for more information.

The ordinary shares trade on The Nasdaq Capital Market, or Nasdaq, under the symbol “FAMI”. On March 18, 2021, the last reported price of the ordinary shares on Nasdaq was $1.38 per ordinary share.

On March 19, 2021, the aggregate market value of our ordinary shares held by non-affiliates was approximately $16,260,024, based on 21,114,303 ordinary shares outstanding, 11,614,303 of which are held by non-affiliates, and a per ordinary share price of $1.40 based on the closing sale price of our ordinary shares on Nasdaq on March 19, 2021. We have not sold any of our ordinary shares pursuant to General Instruction I.B.5 on Form F-3 during the prior 12 calendar month period that ends on and includes the date hereof (but excluding this offering).

Read Full Article

Posted on

Article: Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

Article - Media, Publications

Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates

GLOBE NEWSWIRE, 23 March 2021

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results and business achievements for the fourth quarter and year ended December 31, 2020 and highlighted recent corporate updates.

“2020 was an important momentum-building year for Bionano and one that allowed us to showcase many of our strengths. Despite 2020’s challenges, we executed well on our commercial offerings for Saphyr® by expanding the number of systems in the field and the number of samples analyzed in our data services lab. We believe this progress helped create the awareness needed to develop the market for structural variation analysis and optical genome mapping, or OGM, furthering our goal of disrupting the genomics industry,” said Erik Holmlin, PhD, CEO of Bionano. “2021 is shaping up to be a transformational year for the company. Continue reading “Article: Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates”

Posted on

Article: Farmmi Prices $7.4 Million Underwritten Public Offering of Ordinary Shares

Article - Media, Publications

Farmmi Prices $7.4 Million Underwritten Public Offering of Ordinary Shares

PRNewswire, 22 March 2021

Farmmi, Inc. (“Farmmi” or the “Company”) (NASDAQ: FAMI), an agriculture products supplier in China, today announced the pricing of an underwritten public offering of 6,469,467 ordinary shares of the Company, at a price to the public of $1.15 per share. The closing of the offering is expected to occur on March 24, 2021, subject to customary closing conditions. In addition, the Company has granted the underwriter an option to purchase an additional 15 percent of the ordinary shares offered in the public offering solely to cover over-allotments, if any, exercisable for 25 days, after the closing of this offering, which would bring total gross proceeds to approximately $8.6 million. The Company intends to use the net proceeds from this offering for general corporate and working capital needs.

Read Full Article

Posted on

Article: American Acquisition Opportunity Inc. Announces Pricing of $100,000,000 Initial Public Offering

Article - Media, Publications

American Acquisition Opportunity Inc. Announces Pricing of $100,000,000 Initial Public Offering

ACCESSWIRE , 18 March 2021

American Acquisition Opportunity Inc. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Thursday, March 18, 2021, under the ticker symbol “AMAOU”. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “AMAO” and “AMAOW,” respectively. Continue reading “Article: American Acquisition Opportunity Inc. Announces Pricing of $100,000,000 Initial Public Offering”

Posted on

Article: Form S-1/A Glass Houses Acquisition Corp.

Article - Media, Publications

Form S-1/A Glass Houses Acquisition Corp.

EDGAR AGENTS LLC, 08 March 2021

Glass Houses Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we will not be limited to a particular industry or geographic region in our identification and acquisition of a target company, we intend to focus our search for a target business that provides critical resources and/or services to the technologies powering the 21st century industrial economy.

This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described in this prospectus, and only whole warrants are exercisable. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. We have also granted the underwriter a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments, if any

Read Full Article

Posted on

Article: Nasdaq Futures Tumble As Value Surge Makes Europe A Sea Of Green

Article - Media, Publications

Nasdaq Futures Tumble As Value Surge Makes Europe A Sea Of Green

TYLER DURDEN, 08 March 2021

US equity futures and global markets jumped higher at the reopen of Asian trading late on Sunday following news of the Senate’s passage of the Biden $1.9TN stimulus plan and the spike higher in oil following the Houthi drone attack on Aramco facilities in the Gulf, but have since dipped amid renewed reflationary fears which pushed Treasury yields as high as 1.61% overnight hitting tech stocks with lofty valuations even as value stocks and European markets were broadly in the red. After rising above $71, Brent has since faded gains and was last trading near where it closed Friday at $69. Bitcoin soared as HK-based firm the latest institution to convert cash into Ethereum and Bitcoin.

At 7:10 a.m. ET, Dow e-minis were down 16 points, or 0.07%, S&P 500 e-minis were down 16.5 points, or 0.44%, and Nasdaq 100 e-minis were down 154.25 points, or 1.20%. Continue reading “Article: Nasdaq Futures Tumble As Value Surge Makes Europe A Sea Of Green”

Posted on

Article: Another Market Paradox: Wall Street Struggles To Explain Record Equity Inflows Amid Stock Turmoil

Article - Media, Publications

Another Market Paradox: Wall Street Struggles To Explain Record Equity Inflows Amid Stock Turmoil

TYLER DURDEN, 08 March 2021

Something bizarre is happening in the stock market: for the past three weeks stocks – and especially tech – has gotten hammered, with the Nasdaq briefly sliding into a 10% correction while the S&P has also been hard hit (although one can’t say the same for reflation stocks such as energy which have soared in recent weeks). Some other notable casualties: Apple has tumbled 15% since late January. Tesla has lost more than a quarter-trillion dollars in market value in three weeks, and more than $1.5 trillion has been wiped off the Nasdaq in less than a month.

And yet, despite this hit to risk assets on the back of the recent in surge in interest rates, accompanied by a parallel spike in both the VIX, and its bond market equivalent, the MOVE index. Continue reading “Article: Another Market Paradox: Wall Street Struggles To Explain Record Equity Inflows Amid Stock Turmoil”

Posted on

Article: Mercurity Fintech Holding Inc. Announced Changes to Board Composition

Article - Media, Publications

Mercurity Fintech Holding Inc. Announced Changes to Board Composition

PRNewswire, 04 March 2021

Mercurity Fintech Holding Inc. (the “Company” or “MFH”) (Nasdaq: MFH) today announced that Mr. Cong Huang has been appointed as Independent Director to the Company’s Board of Directors (the “Board”), and Mr. Liu Hao has been appointed as a Director to the Board. These changes were put into effect on March 4, 2021.

Mr. Cong Huang is a renowned researcher and entrepreneur in financial technology innovation. After receiving the PhD degree in Statistics from Yale University, he worked at Columbia University as an Assistant Professor in the Statistics Department, conducting research focused on algorithms and implementations in data mining. After a period of time, he decided to leave campus to develop his career in financial innovation and technology. At Goldman Sachs (GS), he played a pivotal role in developing various new models and algorithms to improve the speed and accuracy of options pricing methods. At McKinsey & Company, he helped financial institutions implement strategic innovation and transformation initiatives. Continue reading “Article: Mercurity Fintech Holding Inc. Announced Changes to Board Composition”

Posted on

Article: 180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement

Article - Media, Publications

180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement

GLOBE NEWSWIRE, 25 February 2021

180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced the closing of its previously announced private placement of 2,564,000 shares of its common stock and accompanying warrants to purchase an aggregate of up to 2,564,000 shares of common stock at a combined purchase price of $4.55 per share and accompanying warrant. The warrants are exercisable immediately at an exercise price of $5.00 per share and expire five years from the date of issuance. Gross proceeds were approximately $11.7 million, before deducting placement agent fees and other offering expenses. The Company currently intends to use the net proceeds from this offering for general corporate purposes, working capital, and for the research and development of the Company’s programs that are not funded by grants.

Read Full Article

Posted on

Article: 180 Life Sciences Corp. Announces $11.7 Million Private Placement

Article - Media, Publications

180 Life Sciences Corp. Announces $11.7 Million Private Placement

GLOBE NEWSWIRE, 19 February 2021

180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it has entered into securities purchase agreements with certain institutional investors to raise approximately $11.7 million through the private placement of 2,564,000 shares of its common stock and accompanying warrants to purchase an aggregate of up to 2,564,000 shares of common stock at a combined purchase price of $4.55 per share and accompanying warrant. The warrants will be exercisable immediately at an exercise price of $5.00 per share and will expire five years from the date of issuance. The closing of the private placement is expected to occur on February 23, 2021, subject to the satisfaction of certain customary closing conditions set forth in the securities purchase agreements.

Read Full Article

Posted on

Article: International brokers sued over naked short selling allegations

Article - Media

International brokers sued over naked short selling allegations

Alex Pugh, SecuritiesFinanceTimes, 12 February 2021

CIBC, Bank of America, UBS and TD Bank stand accused of coordinating “abusive” naked short selling and spoofing strategies in US and Canadian stock markets by a Bermuda hedge fund that claims to have lost tens of millions of dollars as a result.

Read full article.

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?